Compare FMC Corp (FMC) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? FMC Corp trades at $8.95 (market cap $1.39B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.42 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 4.3× FMC Corp's market cap, and FMC Corp pays a 3.59% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold FMC Corp for 68 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| FMC | IOVA | |
|---|---|---|
Market Cap | $1.39B | $6.04B |
Volume | 4,145,979 | 14,805,993 |
Sector | Basic Materials | Health |
52-Week High | $30.63 | $14.82 |
52-Week Low | $8.44 | $1.81 |
Typical Hold Time | 68 Days | 0 Days |
Enterprise Value | $5.19B | $5.97B |
Dividend Yield | 3.59% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC trades at $9.09, up 0.66% with bearish technical signals despite recent earnings beats. The agricultural sciences company faces severe profitability challenges with a -84.83% net margin and negative ROE, though valuation ratios appear attractive with P/S of 0.35 and P/B of 0.86. Recent developments include regulatory filings for new herbicides in Brazil and a minority equity investment from Tessenderlo Group.
While analyst consensus suggests moderate upside to the $14.60 price target, significant operational challenges and negative cash flow from operations in 2025 present substantial risks. The company's aggressive deleveraging efforts and new product pipeline offer potential catalysts, but investors face headwinds from cyclical industry pressures and persistent profitability issues.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
